AB Corporate Bond ETF (NASDAQ:EYEG) Short Interest Down 88.1% in August

by · The Markets Daily

AB Corporate Bond ETF (NASDAQ:EYEG – Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 78 shares, a decrease of 88.1% from the July 30th total of 655 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average trading volume of 861 shares, the short-interest ratio is presently 0.1 days.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in AB Corporate Bond ETF stock. Jane Street Group LLC lifted its stake in shares of AB Corporate Bond ETF (NASDAQ:EYEG – Free Report) by 166.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,741 shares of the specialty pharmaceutical company’s stock after acquiring an additional 9,839 shares during the quarter. Jane Street Group LLC owned approximately 2.10% of AB Corporate Bond ETF worth $563,000 at the end of the most recent reporting period. 64.16% of the stock is currently owned by hedge funds and other institutional investors.

AB Corporate Bond ETF Stock Performance

EYEG traded down $0.06 during mid-day trading on Wednesday, reaching $34.66. 2,085 shares of the company traded hands, compared to its average volume of 280. The stock has a market capitalization of $27.73 million, a P/E ratio of -20.63 and a beta of 0.18. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.01. The company’s fifty day moving average price is $34.85 and its 200-day moving average price is $35.21. AB Corporate Bond ETF has a 52-week low of $34.46 and a 52-week high of $36.63.

AB Corporate Bond ETF Increases Dividend

The business also recently disclosed a monthly dividend, which was paid on Thursday, August 6th. Stockholders of record on Monday, August 3rd were paid a $0.1427 dividend. This is a positive change from AB Corporate Bond ETF’s previous monthly dividend of $0.14. The ex-dividend date was Monday, August 3rd. This represents a c) annualized dividend and a dividend yield of 4.9%. AB Corporate Bond ETF’s dividend payout ratio (DPR) is currently -102.38%.

AB Corporate Bond ETF Company Profile

(Get Free Report)

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Recommended Stories